# Post-Market Surveillance Study of the TM Ardis Interbody Fusion System

> **NCT02429908** · PHASE4 · COMPLETED · sponsor: **Zimmer Biomet** · enrollment: 80 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DEVICE:** TM-Ardis Interbody

## Key facts

- **NCT ID:** NCT02429908
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2018-09-14
- **Final completion:** 2018-09-14
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02429908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02429908, "Post-Market Surveillance Study of the TM Ardis Interbody Fusion System". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02429908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*